Hugo, Safilo renew eyewear license

Article

Hugo Boss Group and Safilo Group announced a license renewal for the BOSS Black, BOSS Orange, and HUGO frames and sunglass collections.

Padua, Italy-Hugo Boss Group and Safilo Group announced recently that the two companies have an renewed their license agreement early with a term until 2020 for the design, production, and worldwide distribution of the BOSS Black, BOSS Orange, and HUGO frames and sunglass collections.

Both companies are pleased by the success of their partnership.

“We are confident that our renewed agreement will continue to ensure to our brands a leading and successful journey in the eyewear category,” said Claus-Dietrich Lahrs, Chairman of the Managing Board of Hugo Boss AG.

Roberto Vedovotto, Chief Executive Officer of Safilo Group, also noted, “The great working relationship that we have developed with such a fantastic group of people at Hugo Boss makes us believe that the turnover of the Hugo Boss brands in the eyewear category will cross the 100 million Euro revenue milestone at full potential.”

For more articles in this issue of InDispensable, click here.

Recent Videos
Dr Jamie Kuzniar discusses higher order aberrations and premium scleral lenses
Abby Gillogly Harsch, OD, FAAO, FSLS, shares a specific complex case of scleral lens fitting that she presented on at this year's GSLS.
Sherrol Reynolds, OD, FAAO, values the ophthalmic-optometric collaboration on display at the summit, running from February 14-17, 2025 in San Juan, Puerto Rico.
Katie Rachon, OD, FAAO, Dipl ABO, shares her excitement for the upcoming conference and what it means for an optometrist's toolbox.
EnVision Summit Cochair Cecelia Koetting, OD, FAAO, Dipl ABO, says that attendees should get ready for more discussion-based panels at this year's conference.
From contact lens dropout to addressing diabetic retinopathy in rural communities, optometrists choose an area of eye care research that they would expand, given the appropriate resources.
Bonnie An Henderson in an interview for the EnVision Summit
© 2025 MJH Life Sciences

All rights reserved.